149 related articles for article (PubMed ID: 18456664)
1. Initiation of mammalian O-mannosylation in vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the alpha-dystroglycan mucin domain.
Breloy I; Schwientek T; Gries B; Razawi H; Macht M; Albers C; Hanisch FG
J Biol Chem; 2008 Jul; 283(27):18832-40. PubMed ID: 18456664
[TBL] [Abstract][Full Text] [Related]
2. Regulation of mammalian protein O-mannosylation: preferential amino acid sequence for O-mannose modification.
Manya H; Suzuki T; Akasaka-Manya K; Ishida HK; Mizuno M; Suzuki Y; Inazu T; Dohmae N; Endo T
J Biol Chem; 2007 Jul; 282(28):20200-6. PubMed ID: 17502374
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.
Tran DT; Lim JM; Liu M; Stalnaker SH; Wells L; Ten Hagen KG; Live D
J Biol Chem; 2012 Jun; 287(25):20967-74. PubMed ID: 22549772
[TBL] [Abstract][Full Text] [Related]
4. Characterization of site-specific O-glycan structures within the mucin-like domain of alpha-dystroglycan from human skeletal muscle.
Nilsson J; Nilsson J; Larson G; Grahn A
Glycobiology; 2010 Sep; 20(9):1160-9. PubMed ID: 20507882
[TBL] [Abstract][Full Text] [Related]
5. O-Mannosylation and human disease.
Dobson CM; Hempel SJ; Stalnaker SH; Stuart R; Wells L
Cell Mol Life Sci; 2013 Aug; 70(16):2849-57. PubMed ID: 23115008
[TBL] [Abstract][Full Text] [Related]
6. Probing the stability of the "naked" mucin-like domain of human α-dystroglycan.
Bozzi M; Di Stasio E; Scaglione GL; Desiderio C; Martelli C; Giardina B; Sciandra F; Brancaccio A
BMC Biochem; 2013 Jul; 14():15. PubMed ID: 23815856
[TBL] [Abstract][Full Text] [Related]
7. Protein O-mannosylation in animal development and physiology: from human disorders to Drosophila phenotypes.
Nakamura N; Lyalin D; Panin VM
Semin Cell Dev Biol; 2010 Aug; 21(6):622-30. PubMed ID: 20362685
[TBL] [Abstract][Full Text] [Related]
8. Protein
Halmo SM; Singh D; Patel S; Wang S; Edlin M; Boons GJ; Moremen KW; Live D; Wells L
J Biol Chem; 2017 Feb; 292(6):2101-2109. PubMed ID: 27932460
[TBL] [Abstract][Full Text] [Related]
9. Recent advancements in understanding mammalian O-mannosylation.
Sheikh MO; Halmo SM; Wells L
Glycobiology; 2017 Sep; 27(9):806-819. PubMed ID: 28810660
[TBL] [Abstract][Full Text] [Related]
10. Drosophila Dystroglycan is a target of O-mannosyltransferase activity of two protein O-mannosyltransferases, Rotated Abdomen and Twisted.
Nakamura N; Stalnaker SH; Lyalin D; Lavrova O; Wells L; Panin VM
Glycobiology; 2010 Mar; 20(3):381-94. PubMed ID: 19969597
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: α-dystroglycan and forms of muscular dystrophy.
Live D; Wells L; Boons GJ
Chembiochem; 2013 Dec; 14(18):2392-402. PubMed ID: 24318691
[TBL] [Abstract][Full Text] [Related]
12. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.
Hara Y; Kanagawa M; Kunz S; Yoshida-Moriguchi T; Satz JS; Kobayashi YM; Zhu Z; Burden SJ; Oldstone MB; Campbell KP
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17426-31. PubMed ID: 21987822
[TBL] [Abstract][Full Text] [Related]
13. Mammalian
Larsen ISB; Narimatsu Y; Joshi HJ; Yang Z; Harrison OJ; Brasch J; Shapiro L; Honig B; Vakhrushev SY; Clausen H; Halim A
J Biol Chem; 2017 Jul; 292(27):11586-11598. PubMed ID: 28512129
[TBL] [Abstract][Full Text] [Related]
14. Protein O-mannosylation across kingdoms and related diseases: From glycobiology to glycopathology.
Hang J; Wang J; Lu M; Xue Y; Qiao J; Tao L
Biomed Pharmacother; 2022 Apr; 148():112685. PubMed ID: 35149389
[TBL] [Abstract][Full Text] [Related]
15. O-Mannose and O-N-acetyl galactosamine glycosylation of mammalian α-dystroglycan is conserved in a region-specific manner.
Gomez Toledo A; Raducu M; Cruces J; Nilsson J; Halim A; Larson G; Rüetschi U; Grahn A
Glycobiology; 2012 Nov; 22(11):1413-23. PubMed ID: 22781125
[TBL] [Abstract][Full Text] [Related]
16. Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal α-dystroglycan O-mannosylation, independent from sialic acid.
Riemersma M; Sandrock J; Boltje TJ; Büll C; Heise T; Ashikov A; Adema GJ; van Bokhoven H; Lefeber DJ
Hum Mol Genet; 2015 Apr; 24(8):2241-6. PubMed ID: 25552652
[TBL] [Abstract][Full Text] [Related]
17. The structure of POMGNT2 provides new insights into the mechanism to determine the functional O-mannosylation site on α-dystroglycan.
Imae R; Kuwabara N; Manya H; Tanaka T; Tsuyuguchi M; Mizuno M; Endo T; Kato R
Genes Cells; 2021 Jul; 26(7):485-494. PubMed ID: 33893702
[TBL] [Abstract][Full Text] [Related]
18. Protein O-mannosylation in metazoan organisms.
Panin VM; Wells L
Curr Protoc Protein Sci; 2014 Feb; 75():12.12.1-12.12.29. PubMed ID: 24510673
[TBL] [Abstract][Full Text] [Related]
19. Mammalian O-mannosylation: unsolved questions of structure/function.
Stalnaker SH; Stuart R; Wells L
Curr Opin Struct Biol; 2011 Oct; 21(5):603-9. PubMed ID: 21945038
[TBL] [Abstract][Full Text] [Related]
20. O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function.
Imperiali M; Thoma C; Pavoni E; Brancaccio A; Callewaert N; Oxenius A
J Virol; 2005 Nov; 79(22):14297-308. PubMed ID: 16254364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
